Detalhe da pesquisa
1.
Safety, pharmacokinetics and antiviral activity of ABI-H2158, a hepatitis B virus core inhibitor: A randomized, placebo-controlled phase 1 study.
J Viral Hepat
; 30(3): 209-222, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36302125
2.
Safety and efficacy of vebicorvir in virologically suppressed patients with chronic hepatitis B virus infection.
J Hepatol
; 77(3): 642-652, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35460726
3.
Safety and efficacy of vebicorvir administered with entecavir in treatment-naïve patients with chronic hepatitis B virus infection.
J Hepatol
; 77(5): 1265-1275, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35697332
4.
Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected With HBV.
Gastroenterology
; 154(4): 989-997, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29174546
5.
Sofosbuvir plus ribavirin with or without peginterferon for the treatment of hepatitis C virus: Results from a phase 3b study in China.
J Gastroenterol Hepatol
; 33(6): 1168-1176, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29380415
6.
Ledipasvir plus sofosbuvir for 12 weeks in patients with hepatitis C genotype 4 infection.
Hepatology
; 64(4): 1049-56, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27351341
7.
Safety and efficacy of ledipasvir/sofosbuvir for the treatment of genotype 1 hepatitis C in subjects aged 65 years or older.
Hepatology
; 63(4): 1112-9, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26704693
8.
A phase 3b study of sofosbuvir plus ribavirin in Taiwanese patients with chronic genotype 2 hepatitis C virus infection.
Liver Int
; 36(8): 1101-7, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26835876
9.
Ledipasvir/sofosbuvir fixed-dose combination tablet in Taiwanese patients with chronic genotype 1 hepatitis C virus.
J Gastroenterol Hepatol
; 31(7): 1323-9, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26841930
10.
Sofosbuvir plus ribavirin for the treatment of chronic genotype 4 hepatitis C virus infection in patients of Egyptian ancestry.
J Hepatol
; 62(5): 1040-6, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25450208
11.
Sofosbuvir plus ribavirin for treating Egyptian patients with hepatitis C genotype 4.
J Hepatol
; 63(3): 581-5, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25937436
12.
Long-term open-label vebicorvir for chronic HBV infection: Safety and off-treatment responses.
JHEP Rep
; 6(4): 100999, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38510983
13.
Efficacy of sofosbuvir plus ribavirin in treatment-naive patients with genotype-1 and -3 HCV infection: results from a Russian Phase IIIb study.
Antivir Ther
; 21(8): 671-678, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27376706
14.
Correlates of disease-specific knowledge among patients with chronic hepatitis B or hepatitis C infection in India.
Hepatol Int
; 10(6): 988-995, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27146692
15.
Chronic hepatitis C virus infection in India: Regional demographics and distribution of viral genotypes.
Indian J Gastroenterol
; 35(6): 469-477, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27844277
16.
A phase IIIb study of ledipasvir/sofosbuvir fixed-dose combination tablet in treatment-naïve and treatment-experienced Korean patients chronically infected with genotype 1 hepatitis C virus.
Hepatol Int
; 10(6): 947-955, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27198664
17.
Elevated Intracranial Pressure and Cerebral Edema following Permanent MCA Occlusion in an Ovine Model.
PLoS One
; 10(6): e0130512, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26121036
18.
Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial.
Lancet Infect Dis
; 15(6): 645-53, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25863559
19.
A surgical model of permanent and transient middle cerebral artery stroke in the sheep.
PLoS One
; 7(7): e42157, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22848737